NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


[profilepress-login id="1"]

Don't have an account? Subscribe

ADVERTISEMENT

ADVERTISEMENT

PrEPLoveLife launched to increase awareness of HIV preventative meds

By Dermot - 15th Feb 2018

According to new research by Gay Community News, 57 per cent of people taking PrEP are getting it from unregulated sources, particularly online providers.

The research undertaken by <em>Gay Community News</em>, on behalf of Teva Pharmaceuticals Ireland, examined a number of areas in relation to PrEP such as; sexual health, sexually transmitted infections (STIs), attitudes on HIV and awareness and use of PrEP amongst the gay community. There were 622 respondents to the survey, of which 97 per cent were male. Teva is a provider of generic PrEP medication.

The research informs a new campaign entitled PrEPLoveLife. This campaign is designed to increase awareness of PrEP amongst groups most at risk of HIV infection and transmission while also informing the general public “on the overall positive effect PrEP has for modern day Ireland, in conjunction with safer sex practices”, according to a press release.

While the research findings show high levels of awareness of PrEP generally, 30 per cent of respondents did not know or were unsure whether it was available in Ireland.

One third of 24-to 30-year olds (33 per cent) – a key target group for HIV risk reduction strategies – were not aware or were unsure that PrEP was available in Ireland; only 10 per cent of respondents are currently using PrEP, with 81 per cent taking it on a daily basis; and of those using PrEP, a majority (57 per cent) said they obtain PrEP from unregulated sources, with the majority doing so online. The next largest sources were pharmacy (18 per cent), an STI clinic (15 per cent) or from a hospital (6 per cent).

On STI testing, the survey found that just 18 per cent of respondents has an STI test at least every three months, 24 per cent do so every six months, 38 per cent at least once a year, but 19 per cent rarely or ever do.

Some 65 per cent of those surveyed said that HIV is a topic of conversation amongst their peers, while almost three-in-five (58 per cent) said they would tell a new partner their HIV status before having sex with that partner.

Also, 55 per cent of those surveyed bring condoms with them on a date, while 43 per cent of respondents would not expect their date to bring condoms.

ADVERTISEMENT

Latest

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT